News
Stada and Xbrane receive approval for Ximluci
Stada and Xbrane have announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has provided a marketing authorisation for Ximluci.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
Stada and Xbrane have announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has provided a marketing authorisation for Ximluci.